Late last year Toowoomba Hospital became the first public hospital in Queensland to provide ground-breaking day surgery to treat benign prostate enlargement.
Urology consultant Dr Devang Desai said the procedure known as Rezum Therapy had been developed in the United States and would help improve the lives of men across the region.
“The procedure was developed to treat benign prostate enlargement, so we should stress it’s not a treatment for prostate cancer,” Dr Desai said.
“It’s performed with a machine that generates steam which is injected into the prostate and over the following few weeks the excess prostate tissue is vaporised.
“The advantages are that it is minimally invasive and can be done in an outpatient setting, using what we call twilight anaesthesia, so this in itself is a great option for patients who, for a variety of reasons, may not be able to have full anaesthesia.
“It does take around three months to deliver its full effect because it uses a vapour so it’s not like surgery where you can expect a result immediately, but for patients with non-cancerous enlargement of the prostate it presents an excellent option.
“There’s also the advantage, particularly for younger patients, that avoiding the surgical removal of the prostate means they have a better chance of retaining their sexual function.”
Darling Downs Health Acting Chief Executive Ms Shirley-Anne Gardiner said the provision of this type of treatment was a great example of the type of patient-centred care delivered by Darling Downs Health.
“Dr Devang Desai has expanded his already astonishing skillset to provide a treatment that was previously unavailable in the public system,” Ms Gardiner said.
“His commitment and passion for bringing the latest and best treatment options to the table is undeniable and we are extremely pleased to be able to offer this innovative treatment.”
Dr Desai said the addition of Rezum Therapy added another choice when it comes to treating benign prostate enlargement.
“There are a number of options we can consider, and this is just another one, but a very good one for those who are suitable,” he said.
“Eligibility for this treatment is determined by the treating team here at the hospital and it is also dependent on the size of the prostate at the time of detection, so with that in mind it would be suited to cases where the enlargement is discovered sooner rather than later.
“We are very pleased to be able to offer this treatment here at Toowoomba Hospital, but it wouldn’t be possible without the great team we have.
“In particular I would like to acknowledge clinical nurse consultant Leigh Cantwell who was instrumental in organising use of the machine we need for the treatment and Carly Dunn, a registered nurse who specialises in urological cases and who is there with us in theatre.”